- Report
- October 2024
- 86 Pages
Global
From €3500EUR$4,174USD£3,094GBP
- Book
- April 2018
North America
The Cancer Biopsy market within the In Vitro Diagnostics (IVD) industry is a rapidly growing sector. It is used to detect and diagnose cancer in patients, and is a key component of the IVD industry. Cancer biopsy tests are used to detect the presence of cancer cells in a sample of tissue taken from the patient. The sample is then analyzed to determine the type and stage of cancer. The results of the biopsy can help guide treatment decisions.
The Cancer Biopsy market is driven by the increasing prevalence of cancer, advances in technology, and the growing demand for early diagnosis and treatment. The market is expected to continue to grow in the coming years, as more advanced tests become available and the demand for early diagnosis and treatment increases.
Some of the major companies in the Cancer Biopsy market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more